• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

猴和人体组织中的脱氧核苷磷酸化酶表现出极大的相似性,而小鼠脱氧胞苷激酶具有不同的底物特异性。

Deoxynucleoside phosphorylating enzymes in monkey and human tissues show great similarities, while mouse deoxycytidine kinase has a different substrate specificity.

作者信息

Habteyesus A, Nordenskjöld A, Bohman C, Eriksson S

机构信息

Department of Biochemistry I, Karolinska Institutet, Stockholm, Sweden.

出版信息

Biochem Pharmacol. 1991 Oct 9;42(9):1829-36. doi: 10.1016/0006-2952(91)90522-7.

DOI:10.1016/0006-2952(91)90522-7
PMID:1657002
Abstract

Three key enzymes in the anabolic phosphorylation of deoxyribonucleosides and deoxyribonucleoside analogs were purified i.e. cytoplasmic thymidine kinase (TK1), mitochondrial thymidine kinase (TK2) and cytoplasmic deoxycytidine kinase (dCK) from human, mouse and monkey liver and spleen. Their subunit structure and substrate specificities were compared. Extensive purification of TK1 and dCK from mouse spleen and TK2 from mouse and monkey livers revealed major polypeptide bands of 25, 30 and 28 kD, respectively, on sodium dodecyl sulphate-polyacrylamide gel electrophoresis which are very similar to the subunit molecular weights of the corresponding human enzymes. Affinity purified polyclonal antibodies against human dCK also cross-reacted with 30 kD bands in extracts from both mouse and monkey spleen. Thus, the molecular weights of the subunits of these three enzymes appeared to be very similar in all three species. TK1 and TK2 from these different sources appeared to have similar substrate specificities against several deoxyribonucleoside analogs. However, mouse dCK differed significantly from monkey and human dCK in its capacity to phosphorylate dAdo and 2',3'-dideoxycytidine (ddCyd) with a Vmax approximately 10-fold lower than that of the two latter enzymes. The Km and Vmax values for dCyd and arabinocytosine appeared to be very similar with the enzymes from all three species. The fact that mouse dCK shows low activity with dAdo and ddCyd explains differences reported previously in the metabolism of dAdo and ddCyd in mouse compared to that in human lymphocytes. These results argue against the use of mice as model systems for human deoxynucleoside metabolism.

摘要

从人、小鼠和猴的肝脏及脾脏中纯化出了脱氧核糖核苷和脱氧核糖核苷类似物合成代谢磷酸化过程中的三种关键酶,即细胞质胸苷激酶(TK1)、线粒体胸苷激酶(TK2)和细胞质脱氧胞苷激酶(dCK)。比较了它们的亚基结构和底物特异性。从小鼠脾脏中对TK1和dCK以及从小鼠和猴肝脏中对TK2进行了广泛纯化,在十二烷基硫酸钠 - 聚丙烯酰胺凝胶电泳上分别显示出主要的25、30和28 kD多肽条带,这与相应人类酶的亚基分子量非常相似。针对人dCK的亲和纯化多克隆抗体也与小鼠和猴脾脏提取物中的30 kD条带发生交叉反应。因此,这三种酶的亚基分子量在所有三个物种中似乎非常相似。来自这些不同来源的TK1和TK2对几种脱氧核糖核苷类似物似乎具有相似的底物特异性。然而,小鼠dCK在磷酸化脱氧腺苷(dAdo)和2',3'-二脱氧胞苷(ddCyd)的能力上与猴和人dCK有显著差异,其最大反应速度(Vmax)比后两种酶低约10倍。对于脱氧胞苷(dCyd)和阿糖胞苷,所有三个物种的酶的米氏常数(Km)和最大反应速度(Vmax)值似乎非常相似。小鼠dCK对dAdo和ddCyd活性较低这一事实解释了先前报道的小鼠与人类淋巴细胞中dAdo和ddCyd代谢的差异。这些结果反对将小鼠用作人类脱氧核苷代谢的模型系统。

相似文献

1
Deoxynucleoside phosphorylating enzymes in monkey and human tissues show great similarities, while mouse deoxycytidine kinase has a different substrate specificity.猴和人体组织中的脱氧核苷磷酸化酶表现出极大的相似性,而小鼠脱氧胞苷激酶具有不同的底物特异性。
Biochem Pharmacol. 1991 Oct 9;42(9):1829-36. doi: 10.1016/0006-2952(91)90522-7.
2
Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs.人胸苷激酶1和2以及脱氧胞苷激酶对抗病毒和细胞抑制核苷类似物的底物特异性比较。
Biochem Biophys Res Commun. 1991 Apr 30;176(2):586-92. doi: 10.1016/s0006-291x(05)80224-4.
3
Stereoisomeric selectivity of human deoxyribonucleoside kinases.人类脱氧核糖核苷激酶的立体异构选择性。
Biochemistry. 1999 Dec 21;38(51):16993-9. doi: 10.1021/bi9908843.
4
Selective assays for thymidine kinase 1 and 2 and deoxycytidine kinase and their activities in extracts from human cells and tissues.胸苷激酶1和2以及脱氧胞苷激酶的选择性测定及其在人细胞和组织提取物中的活性。
Biochem Biophys Res Commun. 1992 Oct 30;188(2):712-8. doi: 10.1016/0006-291x(92)91114-6.
5
Substrate/inhibitor properties of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2) towards the sugar moiety of nucleosides, including O'-alkyl analogues.人脱氧胞苷激酶(dCK)和胸苷激酶(TK1和TK2)对核苷糖部分(包括O'-烷基类似物)的底物/抑制剂特性。
Nucleosides Nucleotides. 1999 Aug;18(8):1883-903. doi: 10.1080/07328319908044850.
6
Increased ratio between deoxycytidine kinase and thymidine kinase 2 in CLL lymphocytes compared to normal lymphocytes.与正常淋巴细胞相比,慢性淋巴细胞白血病(CLL)淋巴细胞中脱氧胞苷激酶与胸苷激酶2的比率增加。
Leuk Res. 1995 Jul;19(7):443-7. doi: 10.1016/0145-2126(94)00153-2.
7
Substrate/inhibitor specificities of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2).人脱氧胞苷激酶(dCK)和胸苷激酶(TK1和TK2)的底物/抑制剂特异性
Adv Exp Med Biol. 1998;431:623-7. doi: 10.1007/978-1-4615-5381-6_120.
8
Differences in kinetic properties of pure recombinant human and mouse deoxycytidine kinase.纯重组人脱氧胞苷激酶和小鼠脱氧胞苷激酶动力学特性的差异。
Biochem Pharmacol. 1995 Jul 17;50(2):163-8. doi: 10.1016/0006-2952(95)00129-n.
9
The enantioselectivity of the cellular deoxynucleoside kinases.细胞脱氧核苷激酶的对映体选择性。
Nucleosides Nucleotides. 1999 Apr-May;18(4-5):807-10. doi: 10.1080/15257779908041567.
10
2 cloning and expression of mouse deoxycytidine kinase. Pure recombinant mouse and human enzymes show differences in substrate specificity.
J Biol Chem. 1994 Sep 30;269(39):24374-8.

引用本文的文献

1
Cladribine modifies functional properties of microglia.克拉屈滨可修饰小胶质细胞的功能特性。
Clin Exp Immunol. 2020 Sep;201(3):328-340. doi: 10.1111/cei.13473. Epub 2020 Jul 6.
2
Distribution of 2-chloro-2'-deoxyadenosine, 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, fludarabine and cytarabine in mice: a whole-body autoradiography study.
Med Oncol. 1999 Dec;16(4):239-44. doi: 10.1007/BF02785869.
3
Safety assessment, in vitro and in vivo, and pharmacokinetics of emivirine, a potent and selective nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1.1型人类免疫缺陷病毒强效选择性非核苷类逆转录酶抑制剂依米韦仑的体内外安全性评估及药代动力学研究
Antimicrob Agents Chemother. 2000 Jan;44(1):123-30. doi: 10.1128/AAC.44.1.123-130.2000.
4
Efficacy of the carbocyclic 2'-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection.碳环2'-脱氧鸟苷核苷BMS-200475在土拨鼠乙型肝炎病毒感染模型中的疗效。
Antimicrob Agents Chemother. 1998 Dec;42(12):3209-17. doi: 10.1128/AAC.42.12.3209.
5
In vivo antiviral activity and pharmacokinetics of (-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine in woodchuck hepatitis virus-infected woodchucks.(-)-顺式-5-氟-1-[2-(羟甲基)-1,3-氧硫杂环戊烷-5-基]胞嘧啶在土拨鼠肝炎病毒感染的土拨鼠体内的抗病毒活性及药代动力学
Antimicrob Agents Chemother. 1997 Oct;41(10):2076-82. doi: 10.1128/AAC.41.10.2076.
6
Cloning and expression of human deoxyguanosine kinase cDNA.人脱氧鸟苷激酶cDNA的克隆与表达
Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):7258-62. doi: 10.1073/pnas.93.14.7258.
7
Deoxyguanosine-resistant leukemia L1210 cells. Loss of specific deoxyribonucleoside kinase activity.抗脱氧鸟苷白血病L1210细胞。特异性脱氧核糖核苷激酶活性丧失。
J Biol Chem. 1993 Jan 5;268(1):405-9.
8
New targets for pyrimidine antimetabolites for the treatment of solid tumours. 2: Deoxycytidine kinase.用于实体瘤治疗的嘧啶抗代谢物新靶点。2:脱氧胞苷激酶。
Pharm World Sci. 1994 Apr 15;16(2):104-12. doi: 10.1007/BF01880661.
9
Interspecies differences in the kinetic properties of deoxycytidine kinase elucidate the poor utility of a phase I pharmacologically directed dose-escalation concept for 2-chloro-2'-deoxyadenosine.
Cancer Chemother Pharmacol. 1995;36(6):524-9. doi: 10.1007/BF00685803.